Bloomberg News
@Bloomberg-News·2.8M subscribers·40.1K videos
Eli Lilly Now Selling Zepbound Vials at 50% Discount
Posted
August 27, 2024
Views
93,882
Likes
793
Comments
66
Engagement
0.91%
August 27, 2024
93,882
793
66
0.91%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
0:27Now PlayingEli Lilly & Co. is now selling vials of its blockbuster weight-loss drug Zepbound to patients for as little as $399 a month as it works to overcome supply shortages of wildly popular shots. #zepbound #ozempic #weightloss #elililly
Patients with a prescription for Zepbound can purchase a month’s supply of single-use vials through Lilly’s direct-to-consumer site starting Tuesday, the company said in a statement. The vials are priced at about half of what shots cost, with a higher dose going for $549 a month.
Zepbound is typically sold in an auto-injector pen. With vials, patients need to fill syringes on their own but it saves Lilly production time, allowing more people to get the drug.
--------
Subscribe to our YouTube channel
Subscribe to Bloomberg Originals
Bloomberg Quicktake brings you global social video spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
Connect with us on…
Breaking News on YouTube
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
